SHANGHAI, Sept. 20, 2019 /PRNewswire/ — Air Liquide and Wuhan GNLaser Equipment Manufacturing Co., Ltd. (GNLaser) inaugurate a laser innovation joint lab at Air Liquide Shanghai Innovation Campus. Through this lab, Air Liquide and GNLaser aim to develop new solutions to improve the efficiency and quality of laser cutting.
With this partnership, Air Liquide will leverage its technical expertise to seek breakthrough gas solutions to push the limits of carbon steel plate cutting, raise laser cutting speed and optimize gas consumption by testing on the latest models of laser equipment manufactured by GNLaser.
With over 100 years of experience in metal fabrication, Air Liquide provides premium gas solutions such as LASALTM for laser cutting and welding, and a wide range of gas handling equipment, hardgoods and safety products.
Yin Feng, General Manager of GNLaser said: "We are very happy to establish a joint lab with Air Liquide. By leveraging the network of specialists of both sides, we will be able to create better laser solutions for the market and contribute to the high-quality industrial development in China."
Nicolas Poirot, Air Liquide China CEO commented: "Our partnership with GNLaser is a strong testament to Air Liquide's open innovation approach. This laser lab is the latest addition to our Shanghai Innovation Campus and we believe that this will contribute to the metal fabrication industry in the country and enhance its global competitiveness."
Air Liquide in China
Air Liquide in China operates nearly 90 plants and employs more than 4,000 employees today. With a strong presence in the key coastal industrial areas, Air Liquide is now expanding into the center, south and west. Its main business activities include industrial and medical gas operations, Engineering & Construction (designing, manufacturing and installing air separation units/hydrogen facilities), as well as Innovation activities.
Air Liquide, a world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 66,000 employees and serves more than 3.6 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide's scientific territory and have been at the core of the company's activities since its creation in 1902.
Air Liquide's ambition is to be a leader in its industry, deliver long term performance and contribute to sustainability. The company's customer-centric transformation strategy aims at profitable growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.
Air Liquide's revenue amounted to 21 billion euros in 2018 and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good indexes.
SOURCE Air Liquide China